Sign up for free insights newsletter
30

Shanghai Tofflon Science Tech

300171SHE

Need professional-grade analysis? Visit stockanalysis.com

CN¥14.85
-0.93%
End of day
Market Cap

$11.37B

P/E Ratio

64.57

Employees

5,417

Dividend Yield

0.71%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-3.476.89-1.390.041.290.85
Calmar27.01-2.090.041.223.86
Sharpe-2.563.51-1.120.020.800.35
Omega0.461.620.741.041.181.07
Martin-63.6673.30-3.620.083.105.86
Ulcer0.571.5812.5512.179.179.06

Shanghai Tofflon Science Tech (300171) Price Performance

Shanghai Tofflon Science Tech (300171) trades on SHE in CNY. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at CNY14.85, down 0.93% from the previous close.

Over the past year, 300171 has traded between a low of CNY11.47 and a high of CNY18.20. The stock has gained 27.7% over this period. It is currently 18.4% below its 52-week high.

Shanghai Tofflon Science Tech has a market capitalization of $11.37B, with a price-to-earnings ratio of 64.57 and a dividend yield of 0.71%.

About Shanghai Tofflon Science Tech

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples, and freeze-thaw system of biological stock solution; and single use technology, such as bioreactor, liquid distribution system, sterile bag, process chromatography, membrane filtration system, and others. It also provides culture medium, such as cell and gene therapy, biomacromolecule drugs, tobitec feeding medium, and other series; bioreactor and fermentation systems, cell factory, perfusion, and complementary systems; preparation systems, such as bio-process vessel and piping, common solutions, and complex injectable formulation systems; and separation and purification systems, including disc centrifuge membrane filtration, chromatography system and columns, alkali lysis, slurry tank, and filters. In addition, the company offers freeze-drying system, including laboratory, production, and special application freeze-drying products, as well as loading and unloading system; and packaging systems, such as packaging solutions, cartoner machine, top-load cartoner machines, bilster machine, solid bottling equipment, labelling machine, and case packer with palletizer machines. Further, it provides resins, API, isolator system, cleaning and sterilization, filling line, and inspection system products; and engineering services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. Tofflon Science and Technology Group Co., Ltd. was founded in 1993 and is headquartered in Shanghai, China.

Compare Shanghai Tofflon Science Tech

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
SHE
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$5.22B
EBITDA
$249.48M
Profit Margin
3.31%
EPS (TTM)
0.23
Book Value
10.32

Technical Indicators

52 Week High
CN¥20.37
52 Week Low
CN¥11.21
50 Day MA
CN¥15.70
200 Day MA
CN¥15.50
Beta
0.54

Valuation

Trailing P/E
64.57
Forward P/E
22.68
Price/Sales
2.18
Price/Book
1.46
Enterprise Value
$7.95B